menu
    • menu

    Company profile for Protara Therapeutics

    Pfanstiehl, a global leader in the manufacture of cGMP high purity, low endotoxin, low metals (HPLE-LM)TM injectable grade excipients.

    Virtual Booth

    Contact Supplier

    Global Pharma Healthcare: Setting the global benchmark in quality, innovation, and care

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

    Virtual Booth

    Contact Supplier

    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Protara is committed to identifying and advancing transformative therapies for people with rare and specialty diseases. The Protara team prioritizes creativity, diverse perspectives and tenacity to expedite our goal of bringing life-changing therapies to people with limited treatment options. We are a diverse team of entrepreneurs, scientists and veteran rare disease and biopharma specialists, dedicated to our mission of disco...
    Protara is committed to identifying and advancing transformative therapies for people with rare and specialty diseases. The Protara team prioritizes creativity, diverse perspectives and tenacity to expedite our goal of bringing life-changing therapies to people with limited treatment options. We are a diverse team of entrepreneurs, scientists and veteran rare disease and biopharma specialists, dedicated to our mission of discovering, developing and delivering breakthrough therapies to people who have limited treatment options.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Protara TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1 Little West 12th Street New York, NY 10014
    Telephone
    Telephone
    +1 646-844-0337
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://protaratx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/protara-therapeutics/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Protara Therapeutics at 44th J.P. Morgan Healthcare Conference
    Protara Therapeutics at 44th J.P. Morgan Healthcare Conference

    07 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/07/3214466/0/en/Protara-Therapeutics-to-Present-at-the-44th-Annual-J-P-Morgan-Healthcare-Conference.html

    GLOBENEWSWIRE
    07 Jan 2026
    Share Share
    Protara Pharma Gets FDA Breakthrough & Fast Track For TARA-002
    Protara Pharma Gets FDA Breakthrough & Fast Track For TARA-002

    05 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/05/3212690/0/en/Protara-Therapeutics-Receives-Both-FDA-Breakthrough-Therapy-and-Fast-Track-Designations-for-TARA-002-in-Pediatric-Patients-with-Lymphatic-Malformations.html

    GLOBENEWSWIRE
    05 Jan 2026
    Share Share
    Protara Announces Closing of $75 Million Public Offering
    Protara Announces Closing of $75 Million Public Offering

    08 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/08/3201966/0/en/Protara-Announces-Closing-of-75-Million-Public-Offering.html

    GLOBENEWSWIRE
    08 Dec 2025
    Share Share
    Protara Announces Proposed Public Offering
    Protara Announces Proposed Public Offering

    04 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/04/3200349/0/en/Protara-Announces-Proposed-Public-Offering.html

    GLOBENEWSWIRE
    04 Dec 2025
    Share Share
    Protara Therapeutics Shares Updated TARA-002 Data
    Protara Therapeutics Shares Updated TARA-002 Data

    03 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/03/3198842/0/en/Protara-Therapeutics-Announces-Updated-Interim-Data-from-Phase-2-ADVANCED-2-Trial-of-TARA-002-in-BCG-Na%C3%AFve-NMIBC-Patients.html

    GLOBENEWSWIRE
    03 Dec 2025
    Share Share
    Protara Therapeutics To Review Phase 2 ADVANCED-2 Trial Data
    Protara Therapeutics To Review Phase 2 ADVANCED-2 Trial Data

    01 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/01/3197457/0/en/Protara-Therapeutics-to-Host-Conference-Call-and-Webcast-to-Review-New-Interim-Data-from-Phase-2-ADVANCED-2-Trial-of-TARA-002-in-BCG-Na%C3%AFve-NMIBC-Patients-on-Wednesday-December-3-20.html

    GLOBENEWSWIRE
    01 Dec 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search